US Stock MarketDetailed Quotes

MLYS Mineralys Therapeutics

Watchlist

14.480
+0.910+6.71%

Close Jul 12 16:00 ET

14.480
0.0000.00%

Post 16:02 ET

718.91MMarket Cap-7916P/E (TTM)

Mineralys Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-49.82%-19.14M

-177.79%-81.17M

-184.52%-28.98M

-172.34%-19.03M

-272.76%-20.39M

-94.21%-12.78M

-100.71%-29.22M

-108.30%-10.19M

-6.99M

-5.47M

Net income from continuing operations

-149.90%-31.51M

-141.28%-71.9M

-168.81%-24.39M

-240.82%-22.76M

-87.39%-12.14M

-66.57%-12.61M

-53.54%-29.8M

-28.10%-9.07M

---6.68M

---6.48M

Depreciation and amortization

--8K

----

--0

----

Other non cash items

-193.45%-2.51M

-957.78%-6.87M

-403.90%-2.07M

---1.96M

---1.98M

---855K

-194.88%-649K

---410K

----

Change In working capital

20,885.25%12.68M

-1,067.62%-7.47M

-332.46%-3.98M

1,663.88%4.11M

-866.16%-7.54M

-106.28%-61K

-81.10%772K

-142.31%-921K

---263K

--984K

-Change in receivables

144.07%119K

---355K

--300K

---219K

---166K

---270K

--0

-Change in prepaid assets

344.22%4.16M

-325.45%-9.53M

30.84%-1.22M

-464.66%-3M

-7,248.98%-3.6M

-1,676.85%-1.7M

-480.31%-2.24M

-1,225.48%-1.77M

---532K

---49K

-Change in payables and accrued expense

339.38%8.4M

-19.82%2.42M

-461.82%-3.06M

2,627.14%7.34M

-465.15%-3.77M

121.30%1.91M

-32.63%3.01M

-58.12%846K

--269K

--1.03M

Cash from discontinued investing activities

Operating cash flow

-49.82%-19.14M

-177.79%-81.17M

-184.52%-28.98M

-172.34%-19.03M

-272.76%-20.39M

-94.21%-12.78M

-100.71%-29.22M

-108.30%-10.19M

---6.99M

---5.47M

Investing cash flow

Cash flow from continuing investing activities

60.11%-55.95M

-637.50%-160.47M

-116.18%-8.09M

105.58%4.01M

-16.14M

-140.25M

-21.76M

50M

-71.76M

Net PPE purchase and sale

---59K

----

--0

----

Net investment purchase and sale

60.15%-55.89M

-637.50%-160.47M

-116.18%-8.09M

105.58%4.01M

---16.14M

---140.25M

---21.76M

--50M

---71.76M

--0

Cash from discontinued investing activities

Investing cash flow

60.11%-55.95M

-637.50%-160.47M

-116.18%-8.09M

105.58%4.01M

---16.14M

---140.25M

---21.76M

--50M

---71.76M

--0

Financing cash flow

Cash flow from continuing financing activities

-42.92%116.21M

58.76%203.25M

106.93%74K

132.80%184K

-100.49%-581K

1,596.85%203.57M

437.62%128.02M

-1.07M

-561K

117.65M

Net common stock issuance

-42.96%116.12M

12,561.02%202.99M

--0

---581K

--203.57M

---1.63M

---1.07M

---561K

--0

Net preferred stock issuance

----

--0

----

444.46%129.65M

--0

--117.65M

Proceeds from stock option exercised by employees

--149K

--258K

--74K

----

--0

----

Net other financing activities

---63K

----

Cash from discontinued financing activities

Financing cash flow

-42.92%116.21M

58.76%203.25M

106.93%74K

132.80%184K

-100.49%-581K

1,596.85%203.57M

437.62%128.02M

---1.07M

---561K

--117.65M

Net cash flow

Beginning cash position

-43.78%49.3M

722.56%87.7M

76.28%86.3M

-21.15%101.14M

759.69%138.25M

722.56%87.7M

656.71%10.66M

214.78%48.96M

--128.26M

--16.08M

Current changes in cash

-18.66%41.11M

-149.84%-38.4M

-195.48%-37M

81.29%-14.84M

-133.08%-37.11M

832.74%50.55M

732.58%77.04M

892.35%38.75M

---79.31M

--112.18M

End cash Position

-34.60%90.42M

-43.78%49.3M

76.28%86.3M

-21.15%101.14M

759.69%138.25M

722.56%87.7M

--48.96M

--128.26M

Free cash flow

-50.28%-19.2M

-177.79%-81.17M

-184.52%-28.98M

-172.34%-19.03M

-272.76%-20.39M

-94.21%-12.78M

-100.71%-29.22M

-108.30%-10.19M

---6.99M

---5.47M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-49.82%-19.14M	-177.79%-81.17M	-184.52%-28.98M	-172.34%-19.03M	-272.76%-20.39M	-94.21%-12.78M	-100.71%-29.22M	-108.30%-10.19M	-6.99M	-5.47M
Net income from continuing operations	-149.90%-31.51M	-141.28%-71.9M	-168.81%-24.39M	-240.82%-22.76M	-87.39%-12.14M	-66.57%-12.61M	-53.54%-29.8M	-28.10%-9.07M	---6.68M	---6.48M
Depreciation and amortization	--8K	----	----	----	----	--0	----	----	----	----
Other non cash items	-193.45%-2.51M	-957.78%-6.87M	-403.90%-2.07M	---1.96M	---1.98M	---855K	-194.88%-649K	---410K	----	----
Change In working capital	20,885.25%12.68M	-1,067.62%-7.47M	-332.46%-3.98M	1,663.88%4.11M	-866.16%-7.54M	-106.28%-61K	-81.10%772K	-142.31%-921K	---263K	--984K
-Change in receivables	144.07%119K	---355K	--300K	---219K	---166K	---270K	--0	--0	--0	--0
-Change in prepaid assets	344.22%4.16M	-325.45%-9.53M	30.84%-1.22M	-464.66%-3M	-7,248.98%-3.6M	-1,676.85%-1.7M	-480.31%-2.24M	-1,225.48%-1.77M	---532K	---49K
-Change in payables and accrued expense	339.38%8.4M	-19.82%2.42M	-461.82%-3.06M	2,627.14%7.34M	-465.15%-3.77M	121.30%1.91M	-32.63%3.01M	-58.12%846K	--269K	--1.03M
Cash from discontinued investing activities
Operating cash flow	-49.82%-19.14M	-177.79%-81.17M	-184.52%-28.98M	-172.34%-19.03M	-272.76%-20.39M	-94.21%-12.78M	-100.71%-29.22M	-108.30%-10.19M	---6.99M	---5.47M
Investing cash flow
Cash flow from continuing investing activities	60.11%-55.95M	-637.50%-160.47M	-116.18%-8.09M	105.58%4.01M	-16.14M	-140.25M	-21.76M	50M	-71.76M	0
Net PPE purchase and sale	---59K	----	----	----	----	--0	----	----	----	----
Net investment purchase and sale	60.15%-55.89M	-637.50%-160.47M	-116.18%-8.09M	105.58%4.01M	---16.14M	---140.25M	---21.76M	--50M	---71.76M	--0
Cash from discontinued investing activities
Investing cash flow	60.11%-55.95M	-637.50%-160.47M	-116.18%-8.09M	105.58%4.01M	---16.14M	---140.25M	---21.76M	--50M	---71.76M	--0
Financing cash flow
Cash flow from continuing financing activities	-42.92%116.21M	58.76%203.25M	106.93%74K	132.80%184K	-100.49%-581K	1,596.85%203.57M	437.62%128.02M	-1.07M	-561K	117.65M
Net common stock issuance	-42.96%116.12M	12,561.02%202.99M	--0	--0	---581K	--203.57M	---1.63M	---1.07M	---561K	--0
Net preferred stock issuance	----	--0	--0	--0	----	----	444.46%129.65M	--0	--0	--117.65M
Proceeds from stock option exercised by employees	--149K	--258K	--74K	----	----	--0	--0	--0	----	----
Net other financing activities	---63K	----	----	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-42.92%116.21M	58.76%203.25M	106.93%74K	132.80%184K	-100.49%-581K	1,596.85%203.57M	437.62%128.02M	---1.07M	---561K	--117.65M
Net cash flow
Beginning cash position	-43.78%49.3M	722.56%87.7M	76.28%86.3M	-21.15%101.14M	759.69%138.25M	722.56%87.7M	656.71%10.66M	214.78%48.96M	--128.26M	--16.08M
Current changes in cash	-18.66%41.11M	-149.84%-38.4M	-195.48%-37M	81.29%-14.84M	-133.08%-37.11M	832.74%50.55M	732.58%77.04M	892.35%38.75M	---79.31M	--112.18M
End cash Position	-34.60%90.42M	-43.78%49.3M	-43.78%49.3M	76.28%86.3M	-21.15%101.14M	759.69%138.25M	722.56%87.7M	722.56%87.7M	--48.96M	--128.26M
Free cash flow	-50.28%-19.2M	-177.79%-81.17M	-184.52%-28.98M	-172.34%-19.03M	-272.76%-20.39M	-94.21%-12.78M	-100.71%-29.22M	-108.30%-10.19M	---6.99M	---5.47M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall